Correlation Between BenQ Medical and Orient Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BenQ Medical and Orient Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BenQ Medical and Orient Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BenQ Medical Technology and Orient Pharma Co, you can compare the effects of market volatilities on BenQ Medical and Orient Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BenQ Medical with a short position of Orient Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BenQ Medical and Orient Pharma.

Diversification Opportunities for BenQ Medical and Orient Pharma

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BenQ and Orient is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding BenQ Medical Technology and Orient Pharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orient Pharma and BenQ Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BenQ Medical Technology are associated (or correlated) with Orient Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orient Pharma has no effect on the direction of BenQ Medical i.e., BenQ Medical and Orient Pharma go up and down completely randomly.

Pair Corralation between BenQ Medical and Orient Pharma

Assuming the 90 days trading horizon BenQ Medical Technology is expected to under-perform the Orient Pharma. But the stock apears to be less risky and, when comparing its historical volatility, BenQ Medical Technology is 4.43 times less risky than Orient Pharma. The stock trades about -0.02 of its potential returns per unit of risk. The Orient Pharma Co is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  2,605  in Orient Pharma Co on September 12, 2024 and sell it today you would earn a total of  1,090  from holding Orient Pharma Co or generate 41.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

BenQ Medical Technology  vs.  Orient Pharma Co

 Performance 
       Timeline  
BenQ Medical Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BenQ Medical Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BenQ Medical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Orient Pharma 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Orient Pharma Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Orient Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

BenQ Medical and Orient Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BenQ Medical and Orient Pharma

The main advantage of trading using opposite BenQ Medical and Orient Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BenQ Medical position performs unexpectedly, Orient Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Pharma will offset losses from the drop in Orient Pharma's long position.
The idea behind BenQ Medical Technology and Orient Pharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Valuation
Check real value of public entities based on technical and fundamental data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data